WO2026110019 - A PROCESS FOR PURIFICATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT
National phase entry is expected:
Publication Number
WO/2026/110019
Publication Date
28.05.2026
International Application No.
PCT/IB2025/061772
International Filing Date
18.11.2025
Title **
[English]
A PROCESS FOR PURIFICATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT
[French]
UN PROCÉDÉ DE PURIFICATION D'UN PRINCIPE ACTIF PHARMACEUTIQUE
Applicants **
FRESENIUS KABI ONCOLOGY LIMITED
Inventors
ACHARYA, Hrishikesh
BISWAL, Tapanjyoti
SHARMA, Suneel Kumar
HANDA, Vishal
TIWARI, Raj Narayan
SINGH, Govind
CABRI, Walter
RICCI, Antonio
Priority Data
202411089618
19.11.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2427 | |
| EPO | Filing, Examination, Granting | 13695 | |
| Japan | Filing, Examination, Granting | 2480 | |
| South Korea | Filing, Examination, Granting | 2668 | |
| USA | Filing, Examination, Granting | 9940 |
Total:
31,210
Contact Us
Abstract[English]
The present invention provides a process for the purification of an active pharmaceutical ingredient with montmorillonite to reduce heavy metal content. Particularly, the present invention provides a purified active pharmaceutical ingredient.[French]
La présente invention concerne un procédé de purification d'un principe actif pharmaceutique avec de la montmorillonite afin de réduire la teneur en métaux lourds. En particulier, la présente invention concerne un principe actif pharmaceutique purifié.